AN1 0.00% 0.6¢ anagenics limited

Ann: Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer, page-10

  1. 389 Posts.
    lightbulb Created with Sketch. 63
    Cellmid just cannot take a trick, can it?

    Just when it announces two months ago that it is in negotiations with a buyer to divest Lyramid, along comes Covid and spoils everything.

    And what have Cellmid/Lyramid been doing about Covid? They have just got OUT of the Covid antibody business. And now they watch Ellumehealth pocket 230 million dollars for going INTO the Covid antigen business.

    Blooming Covid.

    Life can be a beach.
    Last edited by phillit: 10/02/21
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.6¢
Change
0.000(0.00%)
Mkt cap ! $2.768M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $366 61.06K

Buyers (Bids)

No. Vol. Price($)
2 2791334 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 2617059 3
View Market Depth
Last trade - 15.09pm 19/06/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.